Pregnancy Complications, Correlation With Placental Pathology and Neonatal Outcomes.

great obstetrical syndromes high-risk pregnancy low-risk pregnancy neonatal outcome placenta

Journal

Frontiers in clinical diabetes and healthcare
ISSN: 2673-6616
Titre abrégé: Front Clin Diabetes Healthc
Pays: Switzerland
ID NLM: 9918266295306676

Informations de publication

Date de publication:
2021
Historique:
received: 01 11 2021
accepted: 06 12 2021
medline: 31 3 2023
entrez: 30 3 2023
pubmed: 31 3 2023
Statut: epublish

Résumé

We aimed to clarify and contribute to a better comprehension of associations and correlations between placental histological findings, pregnancy evolution, and neonatal outcomes. This is a longitudinal and prospective observational study, performed between May 2015 and May 2019, on 506 pregnant women. Clinical data related to pregnancy outcome, neonatal health status, and placental histology were primarily collected. Twin pregnancies or malformed newborns were excluded and therefore the study was conducted on 439 cases. These cases have been then subdivided into the following study groups: (a) 282 placentas from pathological pregnancies; and, (b) a control group of 157 pregnancies over 33 weeks of gestational age, defined as physiological or normal pregnancies due to the absence of maternal, fetal, and early neonatal pathologies, most of which had undergone elective cesarean section for maternal or fetal indication. A normal placenta was present in 57.5% of normal pregnancies and in 42.5% of pathological pregnancies. In contrast, placental pathology was present in 26.2% of normal pregnancies and 73.8% of pathological pregnancies. Comparison of the neonatal health status with the pregnancy outcome showed that, among the 191 newborns classified as normal, 98 (51.3%) were born from a normal pregnancy, while 93 (48.7%) were born from mothers with a pathological pregnancy. Among the 248 pathological infants, 59 (23.8%) were born from a mother with a normal pregnancy, while 189 (76.2%) were born from pregnancies defined as pathological. Placental histology must be better understood in the context of natural history of disease. Retrospective awareness of placental damage is useful in prevention in successive pregnancy, but their early identification in the evolving pregnancy could help in association with biological markers or more sophisticated instruments for early diagnosis.

Identifiants

pubmed: 36994339
doi: 10.3389/fcdhc.2021.807192
pmc: PMC10012052
doi:

Types de publication

Journal Article

Langues

eng

Pagination

807192

Informations de copyright

Copyright © 2022 Loverro, Di Naro, Nicolardi, Resta, Mastrolia, Schettini, Capozza, Loverro, Loverro and Laforgia.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Dev Biol. 2010;54(2-3):525-30
pubmed: 19876839
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S53-69
pubmed: 26428503
Obstet Gynecol. 2001 Nov;98(5 Pt 1):861-6
pubmed: 11704184
Am J Obstet Gynecol. 2017 Apr;216(4):411.e1-411.e14
pubmed: 28065815
Am J Obstet Gynecol. 2011 Aug;205(2):124.e1-7
pubmed: 21722872
Eur Heart J. 2011 Sep;32(18):2297-303
pubmed: 21632601
Am J Obstet Gynecol. 2016 Jul;215(1 Suppl):S1-S46
pubmed: 26972897
Obstet Gynecol. 2018 Jul;132(1):e44-e52
pubmed: 29939940
Curr Opin Pediatr. 2014 Jun;26(3):370-6
pubmed: 24786370
Placenta. 2009 Aug;30(8):700-4
pubmed: 19535137
Pediatr Dev Pathol. 2016 Mar-Apr;19(2):165-8
pubmed: 26457860
N Engl J Med. 2017 Aug 17;377(7):613-622
pubmed: 28657417
Best Pract Res Clin Obstet Gynaecol. 2011 Jun;25(3):313-27
pubmed: 21388889
J Perinat Med. 2018 Aug 28;46(6):613-630
pubmed: 30044764
Placenta. 2015 Dec;36(12):1490-3
pubmed: 26565600
Placenta. 2016 Dec;48 Suppl 1:S47-S53
pubmed: 27817870
Best Pract Res Clin Obstet Gynaecol. 2011 Jun;25(3):301-11
pubmed: 21109492
Am J Obstet Gynecol. 2010 Dec;203(6):579.e1-9
pubmed: 20851370
J Matern Fetal Neonatal Med. 2012 Dec;25(12):2704-7
pubmed: 22746184
Placenta. 2013 Aug;34(8):681-9
pubmed: 23684379
Arch Pathol Lab Med. 2016 Jul;140(7):698-713
pubmed: 27223167
Obstet Gynecol. 2006 May;107(5):1049-55
pubmed: 16648410
J Dev Orig Health Dis. 2013 Jun;4(3):249-55
pubmed: 23828732
Metabolites. 2020 Aug 27;10(9):
pubmed: 32867274

Auteurs

Maria Teresa Loverro (MT)

Department of Biomedical Science and Human Oncology, Section of Neonatology and Neonatal Intensive Care, Azienda Ospedaliero-Universitaria Policlinico di Bari, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Edoardo Di Naro (E)

Department Interdisciplinary Medicine, Unit of Obstetrics and Gynecology, Azienda Ospedaliero-Universitaria Policlinico di Bari, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Vittorio Nicolardi (V)

Department of Economics and Finance University of Bari "Aldo Moro", Bari, Italy.

Leonardo Resta (L)

Department Emergency and Organ Transplantation, Institute of Pathology, Azienda Ospedaliero-Universitaria Policlinico di Bari, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Salvatore Andrea Mastrolia (SA)

Department of Obstetrics and Gynecology, Ospedale dei Bambini "Vittore Buzzi", University of Milan, Milan, Italy.

Federico Schettini (F)

Department of Biomedical Science and Human Oncology, Section of Neonatology and Neonatal Intensive Care, Azienda Ospedaliero-Universitaria Policlinico di Bari, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Manuela Capozza (M)

Department of Biomedical Science and Human Oncology, Section of Neonatology and Neonatal Intensive Care, Azienda Ospedaliero-Universitaria Policlinico di Bari, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Matteo Loverro (M)

Department of Women and Child Health, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

Giuseppe Loverro (G)

Department Interdisciplinary Medicine, Unit of Obstetrics and Gynecology, Azienda Ospedaliero-Universitaria Policlinico di Bari, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Nicola Laforgia (N)

Department of Biomedical Science and Human Oncology, Section of Neonatology and Neonatal Intensive Care, Azienda Ospedaliero-Universitaria Policlinico di Bari, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Classifications MeSH